Lentivirus vector HPV16 E6 and E7 with Tet-responsive promoter.
Drawn by SnapGene® software |
|
Clone info. | Lentivirus vector construct of transforming protein E6 and E7 region of human papillomavirus type 16 (HPV16) driven by Tet-responsive promoter and hKO1-2A-rtTA marker driven by UbC promoter. |
---|---|
Comment | The HPV16-E6/E7 genomic DNA subcloned into pENTR201 was a kind gift of Dr. Kiyono (National Cancer Center Research Institute, Japan). Expression was confirmed by the depositor with flowcytometer or fluorescence microscopy. Commonly requested with pCMV-VSV-G-RSV-Rev (RDB04393) and pCAG-HIVgp (RDB04394). |
Vector backbone | CSIV-TRE-RfA-UbC-KT (RDB12878) (Plasmid) |
Selectable markers | Ampicillin (E. coli). Please note that Zeo resistance marker is not included in the lentivirus produced from this vector. |
Growth conditions | LB+Ampicillin, 37oC |
Growth remarks | Use host strain suitable for plasmid clones containing repeat elements and unstable inserts. |
Gene/insert name | Hum_Papillomavirus E6 (HPV16gp1) genomic DNA Hum_Papillomavirus E7 (HPV16gp2) genomic DNA |
Depositor|Developer | Nakamura, Yukio | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Ordering instruction.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Kurita R. et al. PLos One, 8(3): e59890, 2013) Additional terms and conditions: The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit academic purpose. When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Karasawa, S. et al., Biochem. J. 381: 307-312 (2004). The RECIPIENT agrees to expressly describe the late Dr. Hiroyuki Miyoshi as the Developer of the lentivirus vector. |
Remarks | Remember that you will be working with samples containing infectious virus. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 遺伝子組換え生物の受入れ確認書が必要です。当室にご請求ください。 手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Kurita R. et al. PLos One, 8(3): e59890, 2013)。 付加的使用条件: 本件研究材料は、非営利機関の非営利学術研究に限って提供する。 When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Karasawa, S. et al., Biochem. J. 381: 307-312 (2004). レンチウイルスベクターについて、本件研究材料を利用した研究結果等を発表する際は、レンチウイルスベクターが故三好浩之博士により開発されたことを明示する。 |
備考 | このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB17719 | CSIV-TRE-HPV-E6/E7-UbC-KT | DNA solution |
Materials & Methods section:
The CSIV-TRE-HPV-E6/E7-UbC-KT was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB17719). |
Reference section:
Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., Nakamura, Y., Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS One 8 (3): e59890 (2013). PMID 23533656. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
original | Kurita, R., Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS One 8 (3): e59890 (2013). PMID 23533656. [link to RRC of NBRP] |
---|---|
reference | Trakarnsanga, K., An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells. Nat Commun. 2017 Mar 14;8:14750 (2017). PMID 28290447. |
Featured content